WOLVERINE ASSET MANAGEMENT LLC - IRONWOOD PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$41,217,000
-0.2%
40,592,000
+2.5%
0.40%
+4.4%
Q4 2021$41,310,000
+32.9%
39,592,000
+38.5%
0.38%
+43.7%
Q3 2021$31,072,000
-0.5%
28,592,0000.0%0.27%
+12.6%
Q2 2021$31,218,000
-13.5%
28,592,000
-14.4%
0.24%
-22.0%
Q1 2021$36,107,000
-0.3%
33,392,0000.0%0.30%
+14.7%
Q4 2020$36,208,000
+5.5%
33,392,0000.0%0.27%
-12.8%
Q3 2020$34,322,000
-2.1%
33,392,0000.0%0.30%
-13.4%
Q2 2020$35,072,000
+0.6%
33,392,0000.0%0.35%
-30.4%
Q1 2020$34,855,000
-10.7%
33,392,0000.0%0.51%
+11.7%
Q4 2019$39,039,000
+16.7%
33,392,0000.0%0.45%
+6.8%
Q3 2019$33,442,000
-14.9%
33,392,000
-8.9%
0.42%
-17.3%
Q2 2019$39,287,000
-3.3%
36,667,0000.0%0.51%
-7.4%
Q1 2019$40,648,000
+17.4%
36,667,0000.0%0.55%
+33.2%
Q4 2018$34,610,000
-27.3%
36,667,0000.0%0.42%
-24.9%
Q3 2018$47,613,000
-2.9%
36,667,000
+0.4%
0.55%
-12.8%
Q2 2018$49,036,000
+7.3%
36,528,000
-5.4%
0.64%
+7.4%
Q1 2018$45,680,000
+9.1%
38,623,000
+7.4%
0.59%
+39.4%
Q4 2017$41,869,000
-2.1%
35,968,0000.0%0.42%
-10.5%
Q3 2017$42,764,000
+3.1%
35,968,000
+16.1%
0.47%
-10.1%
Q2 2017$41,494,000
+13.7%
30,968,000
+5.8%
0.53%
-6.9%
Q1 2017$36,495,000
+8.2%
29,268,000
+0.1%
0.57%
+29.8%
Q4 2016$33,734,000
-3.4%
29,241,000
+0.0%
0.44%
-16.5%
Q3 2016$34,936,000
+15.0%
29,228,0000.0%0.52%
+13.2%
Q2 2016$30,389,00029,228,0000.46%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
K2 PRINCIPAL FUND, L.P. 9,000$9,953,0000.83%
CSS LLC/IL 10,119,000$11,031,0000.46%
DeepCurrents Investment Group LLC 13,556,000$14,917,0000.45%
TENOR CAPITAL MANAGEMENT Co., L.P. 10,000,000$11,014,0000.24%
WOLVERINE ASSET MANAGEMENT LLC 28,592,000$31,218,0000.24%
HBK INVESTMENTS L P 14,616,000$15,971,0000.06%
PALISADE CAPITAL MANAGEMENT, LP 2,127,000$2,334,0000.05%
Verition Fund Management LLC 3,942,000$4,304,0000.04%
LAZARD ASSET MANAGEMENT LLC 10,037,000$10,959,0000.01%
Calamos Advisors LLC 2,423,000$2,648,0000.01%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders